Labeler · US market

Parke-Davis Div of Pfizer Inc

Parke-Davis Div of Pfizer Inc is a US drug labeler with US FDA registrations covering 10 drug concepts (6 currently active) across 14 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes0071

Active drugs6

Registrations6 active / 13

Packages14

Sole supplier of0 drugs

Portfolio10 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Gemfibrozil tablet, film coated	rx	1	2	SUPPLYING
Ethosuximide solution	rx	1	1	SUPPLYING
Ethosuximide capsule	rx	1	1	SUPPLYING
Phenytoin tablet, chewable	rx	1	1	SUPPLYING
Phenelzine Sulfate tablet, film coated	rx	1	1	SUPPLYING
Methsuximide capsule	rx	1	1	SUPPLYING
Gabapentin capsule	rx	3	3	DISCONTINUED
Pregabalin capsule	rx	2	2	DISCONTINUED
Gabapentin tablet, film coated	rx	1	1	DISCONTINUED
Gabapentin solution	rx	1	1	DISCONTINUED

At a glance

TypeLabeler
Labeler codes0071
Filing names1
Drugs (active)6
Drugs (all time)10
US registrations13
Packages14

Recent events

Shortages, recalls, and registration changes across all filing names.

Feb 10, 2026
RESOLVEDShortage resolved: Gemfibrozil Tablet (Pfizer Inc.)
Feb 10, 2026
SHORTAGEDrug shortage: Gemfibrozil Tablet (Pfizer Inc.)
Sep 12, 2019
RECALLRecall (Class III): Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis…
Jan 11, 2016
RECALLRecall (Class II): Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY…
Jan 11, 2016
RECALLRecall (Class II): Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.